Joery Goossens
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.
Journal: Journal of Alzheimer's disease : JAD
Published: November 07, 2022
TSPO PET upregulation predicts epileptic phenotype at disease onset independently from chronic TSPO expression in a rat model of temporal lobe epilepsy.
Journal: NeuroImage. Clinical
Published: March 03, 2021
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Journal: Alzheimer's research & therapy
Published: October 15, 2017
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.
Journal: Biomarkers in medicine
Published: January 24, 2017
No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis.
Journal: Alzheimer's research & therapy
Published: December 08, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
Journal: Journal of Alzheimer's disease : JAD
Published: September 17, 2016
A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
Journal: Journal of Alzheimer's disease : JAD
Published: August 29, 2016
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: February 03, 2016
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
Journal: Frontiers in neurology
Published: March 26, 2015
TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.
Journal: Acta neuropathologica communications
Published: January 28, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026